HD203
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HD203, covering 2014-07-15 to 2014-07-15. Get the full timeline:
Most recent: Clinical Trial Update: Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients [Phase 3]